1249942

Travere Therapeutics, Inc. — FEI 3018103118

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Diego, CA (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)